MTOX1016
OATP1B3 Knockout HepaRG™ Cells
human female liver (hepatocarcinoma and hepatitis C tumor)
About This Item
Recommended Products
product name
OATP1B3 Knockout HepaRG™ Cells, 1 vial
biological source
human female liver (hepatocarcinoma and hepatitis C tumor)
form
liquid
OMIM accession no.
storage temp.
−196°C
Gene Information
human ... OATP1B3(28234)
General description
Application
Features and Benefits
- The frame-shift mutation of SLCO1B3 gene was confirmed by fragment length analysis and DNA sequencing.
- Loss of functionality was confirmed by loss of transport of selective substrates in sandwich culture assay.
Quality
Legal Information
Disclaimer
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Oral drug delivery involves dissolution in the small intestine and absorption across the enterocyte barrier into the portal vein followed by subsequent delivery through the liver into the systemic circulation.
Related Content
Successful screening for drug targets and lead discovery requires tested, fit-for-process, high-throughput reagents and supplies. Find tools right for your CRO, pharma or biotech processes for both small molecule and biologics screening, and robust immunogenicity testing for therapeutic safety.
High-throughput reagents for drug target screening and immunogenicity testing.
High-throughput reagents for drug target screening and immunogenicity testing.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service